Annual Revenue ($)

Bristol-Myers Squibb revenue was $42.52 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$20.78 b$22.56 b$26.15 b$42.52 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$5.19 b$5.7 b$5.69 b$5.92 b$6.27 b$6.01 b$10.78 b$10.13 b$10.54 b$11.07 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Bristol-Myers Squibb revenue breakdown by business segment: 30.3% from Eliquis, 27.6% from Opdivo, 11.4% from Orencia, 8.1% from Sprycel, 5.7% from Yervoy, 6.4% from Other Brands and 10.6% from Other

Bristol-Myers Squibb revenue breakdown by geographic segment: 58.7% from United States, 24.0% from Europe, 15.3% from Rest of World and 2.0% from Other

FY, 2019FY, 2018FY, 2017
Eliquis$7.93 b$6.44 b$4.87 b
Opdivo$7.2 b$6.74 b$4.95 b
Orencia$2.98 b$2.71 b$2.48 b
Sprycel$2.11 b$2 b$2.01 b
Yervoy$1.49 b$1.33 b$1.24 b
Empliciti$357 m$247 m$231 m
Baraclude$555 m$744 m$1.05 b
Other Brands$1.67 b$2.36 b$3.95 b
Revlimid$1.3 b
Pomalyst/Imnovid$322 m
Abraxane$166 m
Inrebic$5 m
Vidaza$58 m
FY, 2019FY, 2018FY, 2017
United States$15.34 b$12.59 b$11.36 b
Europe$6.27 b$5.66 b$4.99 b
Rest of World$4.01 b$3.73 b$3.88 b
Other$524 m$584 m$553 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu